tirzepatide and pancreatitis Risk: What You Need to Know Study: Tirzepatide Lowers Risk of

Where the Research Stands: Clinical Trials So Far The most detailed data on MariTide come from its Phase 2 trial, which included weekly and monthly regimens compared with placebo

Exenatide attenuates obesity-induced mitochondrial dysfunction by activating sirt1 in renal tubular cells

Circulating metabolomic profiling constitutes a promising tool to address these limitations

Perivascular fat attenuation, inflammation, and coronary artery function

GLP-3 RT (RETATRUTIDE) Description: GLP-3 RT (Retatrutide) is an investigational unimolecular triple agonist of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR)